South Korea
· Delayed Price · Currency is KRW SD Biosensor Company Description
SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally.
The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests.
Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters.
The company was founded in 2010 and is headquartered in Suwon, South Korea.
| Country | South Korea |
| Founded | 2010 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 576 |
Contact Details
Address: 16 Deokyeong-daero Suwon, 16690 South Korea | |
| Phone | 82 31 300 0400 |
| Website | sdbiosensor.com |
Stock Details
| Ticker Symbol | 137310 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7137310009 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Tae Young Heo | President and Chief Executive Officer |
| Hyo Keun Lee | Vice Chairman and Chief Executive Officer |
| Chul-Gyu Oh | Chief Financial Officer and Director |